Treatment of Chronic Pain in Older PeopleEvidence-Based Choice of Strong-Acting Opioids

被引:0
作者
Annette L. van Ojik
Paul A. F. Jansen
Jacobus R. B. J. Brouwers
Eric N. van Roon
机构
[1] University Medical Center,Expertise Centre for Pharmacotherapy in Old Persons (Ephor)
[2] Medical Centre Leeuwarden,Department of Clinical Pharmacy & Pharmacology
[3] University Medical Centre,Department of Geriatrics
[4] University of Groningen,Department of Pharmacotherapeutics and Pharmaceutical Care
关键词
Morphine; Fentanyl; Buprenorphine; Oxycodone; Hydromorphone;
D O I
10.1007/BF03262278
中图分类号
学科分类号
摘要
In the treatment of chronic malignant and non-malignant pain, opioids are used as strong analgesics. Frail elderly patients often have multiple comorbidities and use multiple medicines, leading to an increased risk of clinically relevant drug-drug and drug-disease interactions. Age-related changes and increased frailty may lead to a less predictable drug response, increased drug sensitivity, and potential harmful drug effects. As a result, physicians face a complex task in prescribing medication to elderly patients. In this review, the appropriateness of the strong-acting opioids buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone and tapentadol is determined for use in elderly patients. Evidence-based recommendations for prescribing strong opioids to the frail elderly are presented.
引用
收藏
页码:615 / 625
页数:10
相关论文
共 117 条
[1]  
Gianni W.(2009)Opioids for the treatment of chronic non-cancer pain in older people Drugs Aging 26 63-73
[2]  
Ceci M.(2012)Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analysis Pain 153 265-8
[3]  
Bustacchini S.(2011)Opioid dose and drug-related mortality in patients with nonmalignant pain Arch Intern Med 171 686-91
[4]  
Moore R.A.(1992)Geriatric pharmacology: basic and clinical considerations Ann Rev Pharmacol Toxicol 32 271-302
[5]  
Straube S.(2004)Drug therapy in the elderly Exp Gerontol 39 1731-8
[6]  
Eccleston C.(2007)Pharmacodynamics in older adults: a review Am J Geriatr Pharmacother 5 263-303
[7]  
Gomes T.(1998)Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications Clin Pharmacokinet 34 49-64
[8]  
Mamdani M.M.(2011)Criteria for drug selection in frail elderly persons Drugs Aging 28 391-402
[9]  
Dhalla I.A.(1991)Explicit criteria for determining inappropriate medication use in nursing home residents UCLA Division of Geriatric Medicine. Arch Intern Med 151 1825-32
[10]  
Tumer N.(2005)Transdermal buprenorphine in clinical practice: a post-marketing surveillance study in 13179 patients Cur Med Res Opin 21 1147-56